Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06289985 · ClinicalTrials.gov registry record · NA
StrokeNet Thrombectomy Endovascular Platform
A NA study of Ischemic Stroke, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 1,600
- Enrollment target
- 20
- Study locations
NCT06289985 is a NA study of Ischemic Stroke that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 1,600 participants, above the 1,439-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (11% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT06289985, a NA study of Ischemic Stroke, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,600 participants
- Enrollment target
- 20
- Study locations
Study Summary
STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).
Conditions Studied
Interventions
- DEVICE Endovascular thrombectomy with any FDA-approved category POL or NRY device
- OTHER Medical Management
Study Locations (20)
California
- UCSD Health La Jolla - La Jolla
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- Ronald Reagan UCLA Medical Center - Los Angeles
- UCSD Medical Center - Hillcrest Hospital - San Diego
- Stanford University Medical Center - Stanford
Connecticut
- Hartford Hospital - Hartford
- Yale New Haven Hospital - New Haven
Florida
- Jackson Memorial Hospital - Miami
- Tampa General Hospital - Tampa
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston Medical Center - Boston
Minnesota
- M Health Fairview Southdale Hospital - Edina
- M Health Fairview University of Minnesota Medical Center - Minneapolis
Alabama
- University of Alabama Hospital - Birmingham
Georgia
- Grady Memorial Hospital - Atlanta
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2025-01-31 |
| Est. Completion | 2030-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06289985
The ClinicalTrials.gov registry entry for NCT06289985 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,439-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (11% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Endovascular thrombectomy with any FDA-approved category POL or NRY device is the first listed.
NCT06289985 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT06289985 about?
NCT06289985 is a clinical study titled "StrokeNet Thrombectomy Endovascular Platform". STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).
What is the current status of trial NCT06289985?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,600 participants. The study started on 2025-01-31. Estimated completion is 2030-01-31.
What conditions does trial NCT06289985 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT06289985?
The interventions under investigation include: Endovascular thrombectomy with any FDA-approved category POL or NRY device (DEVICE), Medical Management (OTHER).
Who is sponsoring clinical trial NCT06289985?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06289985 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Virtual Reality Based Rehabilitation After Ischemic Stroke
RECRUITING · NA
-
K01 Impacts of Lingual Endurance Exercise
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.